Business
Press Release (Revised) Oct 03 2023
Strides Pharma Science Limited has informed the Exchange regarding a revised press release dated October 03, 2023, titled "This has reference to the Press Release issued by the Company on September 23, 2023 titled as Strides receives USFDA approval for Icosapent Ethyl Capsules The said press release has been updated with some additional information on the Product and the revised Press release is attached herewith for your records.".
About this update from Strides Pharma Science Ltd
Strides Pharma Science Limited has informed the Exchange regarding a revised press release dated October 03, 2023, titled "This has reference to the Press Release issued by the Company on September 23, 2023 titled as Strides receives USFDA approval for Icosapent Ethyl Capsules The said press release has been updated with some additional information on the Product and the revised Press release is attached herewith for your records.". View Attachment
View stock analysis, news, and events for Strides Pharma Science Ltd